Categories AlphaGraphs, Earnings, Energy

CHK Earnings: Highlights of Chesapeake Energy’s Q4 2022 results

Chesapeake Energy Corp. (NYSE: CHK) has reported a sharp increase in earnings for the fourth quarter of 2022 when the energy company’s revenues grew in double digits.

Chesapeake Energy Q4 2022 earnings infographic

Adjusted profit increased a whopping 77% year-over-year to $4.22 per share in the fourth quarter. Net income, on an unadjusted basis, more than doubled to $3.51 billion or $24.0 per share. Earnings benefited from a 34% surge in revenues to $4.13 billion.

The company produced approximately 4.05 bcfe/d net (90% natural gas) during the quarter. Looking ahead, the management expects capital expenditures to be between $1.765 billion and $1.835 billion in fiscal 2023.

Read management/analysts’ comments on quarterly earnings reports

“Behind our disciplined capital allocation, proactive hedging program, and strong balance sheet, we anticipate generating significant free cash flow from operations. When combined with proceeds from recent Eagle Ford divestitures, we expect that our plan will allow us to again deliver our leading shareholder return framework in the year ahead,” said Chesapeake’s CEO Nick Dell’Osso.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Key takeaways from Cintas’ (CTAS) third-quarter 2023 report

Cintas Corporation (NASDAQ: CTAS) has been growing its market share by diversifying into new areas and through acquisitions. The prudent business model, with a focus on recurring revenues, has helped

Here are a few points to keep in mind if you are considering Starbucks Corporation (SBUX)

Shares of Starbucks Corporation (NASDAQ: SBUX) stayed in green on Thursday. The stock has gained 10% over the past 12 months. The company delivered healthy results for its most recent

ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by 9%. The company also provided guidance for fiscal

Add Comment
Viewing Highlight